MedPath

Study for hair and nail problems.

Phase 2
Completed
Registration Number
CTRI/2022/08/044667
Lead Sponsor
Transformative Learning Solutions Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
36
Inclusion Criteria

1.Female subjects in general good health.

2.Subjects in the age group 18-55 years (both the ages inclusive).

3.Subjects complaining of hair fall and damage.

4.Subjects willing to give a written informed consent and willing to abide by and comply with the study protocol.

5.Hair density of >100 and <200 hair follicle per square cm as per Trichoscan measurement.

6.Female Subjects falling under Grade 3 - Grade 6 of hair loss severity grade evaluated as per MSCR photo numerical 10-point scale (Linear scale for assessment purpose-In Use Scale).

7.Subjects with inferior and poor nail quality (cracked or brittle nails, vertical ridges, dark discolorations, yellow fingernails etc). Subjects with score less than 5 for nail health assessment.

Exclusion Criteria

1.Subjects who have undergone hair growth treatment within 3

months before screening into the study.

2.Subjects having any active scalp disease which may interfere in

the study â?? dermatologistâ??s judgement.

3.Subjects having nail psoriasis or other conditions that requires

medical attention

4.Subjects with irreversible hair or nail conditions, due to which the

assessment is not possible

5.Subjects who have undergone chemotherapy for cancer in the 6

months prior to start of the study or have a plan to do treatments

during study.

6.Subjects who have history of alcoholism, smoking, crash dieting

and/ or psychiatric disorder including trichotillomania.

7.Subjects who have had hair transplant, who have taken

pharmaceutical product which cause hirsutism (ex. phenytoin) and

finasteride for androgenic alopecia, under medical treatment for hair

problems.

8.Subjects who have nail problems due to fungal infections

9.Subjects who consume vitamins and food supplements that may

interfere with the study.

10.Subjects with poor nail quality due to fungal infection or subjects

with nail psoriasis will be excluded.

11.Subjects who wear wig or hair extensions

12.Subjects who wear nail extensions or nail jewellery

13.Subjects who disagree to not wear nail polish during the study

period

14.A known history or present condition of allergic response to any

pharmaceutical product/Ayurvedic/nutraceutical product and with any

trauma to nails

15.Subjects on oral medications, undergoing any chemical hair salon

treatment-straightening / perming / colour/ henna which will

compromise the study.

16.Subjects with chronic illness which may influence the study.

17.Subjects who are pregnant or lactating or nursing as established

with medical history

18.Menopausal female subjects as determined by medical history.

19.Subjects participating in other similar cosmetic or therapeutic trial

within last three months.

20.Subjects with any history of underlying uncontrolled medical

illness including diabetes mellitus, hypertension, HIV, hepatitis,

severe anemia, serious disorder of heart and respiratory apparatus

or any other serious medical illness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Change in hair growth rate, hair density, hair <br/ ><br>thickness, hair thinning. <br/ ><br>2. Reduction in hair fall. <br/ ><br>3. New hair growth. <br/ ><br>4. Improvement in scalp condition <br/ ><br>5. Improvement in smoothness <br/ ><br>6. Improvement in Shine/gloss <br/ ><br>7. Change in nail quality (cracked or brittle nails, <br/ ><br>vertical ridges, dark discolorations, yellow <br/ ><br>fingernails) and Moisture/hydration by <br/ ><br>dermatological visual assessment. <br/ ><br>8. Change in nail growth by length measurementTimepoint: Day1, Day 3, Day 32, Day 62 and Day 92
Secondary Outcome Measures
NameTimeMethod
The product safety profile by dermatologistTimepoint: Day1, Day 3, Day 32, Day 62 and Day 92
© Copyright 2025. All Rights Reserved by MedPath